Exact Mass: 392.1336271999999
Exact Mass Matches: 392.1336271999999
Found 195 metabolites which its exact mass value is equals to given mass value 392.1336271999999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Shanziside
C16H24O11 (392.13185539999995)
Shanzhiside is a terpene glycoside. Shanzhiside is a natural product found in Barleria lupulina, Gardenia jasminoides, and other organisms with data available. Shanziside is a iridoid glucoside isolated from Phlomis tuberosa L[1]. Shanziside is a iridoid glucoside isolated from Phlomis tuberosa L[1].
7-Ethyl-10-hydroxycamptothecin
SN-38 is a member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a drug metabolite and an antineoplastic agent. It is a pyranoindolizinoquinoline, a delta-lactone, a tertiary alcohol and a member of phenols. 7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others. 7-Ethyl-10-hydroxycamptothecin is a natural product found in Apis cerana with data available. A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin (SN38) is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold. SN38 is metabolized via glucoronidation by UGT1A1. (Wikipedia) 7-Ethyl-10-hydroxycamptothecin (SN38), the active metabolite of irinotecan, exerts a 100-fold to 1000-fold higher effect than irinotecan itself against several tumor cell lines. (PMID: 23233044) Among five chemotherapeutic agents commonly used for breast cancer treatment, only an irinotecan metabolite SN38 showed additive antitumor activity with olaparib. (PMID: 22454224) Metabolism of irinotecan to SN38 is inefficient and subject to considerable patient-to-patient variability. One approach to more controlled administration of the anticancer agent is direct administration of the active SN38. (PMID: 23299391) A member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4]. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4].
Caryoptosidic acid
C16H24O11 (392.13185539999995)
Caryoptosidic acid is found in herbs and spices. Caryoptosidic acid is a constituent of Lippia graveolens (Mexican oregano) Constituent of Lippia graveolens (Mexican oregano). Caryoptosidic acid is found in herbs and spices.
Cloprednol
Fenflumizole
C23H18F2N2O2 (392.1336271999999)
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
Shanzhiside
C16H24O11 (392.13185539999995)
(1S,4aS,5R,7S,7aS)-5,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
Dehydrorotenone
Semiglabrin
Pseudosemiglabrin
Stachyoidin
Hookerianin
Dehydrodeguelin
Dehydrodeguelin,7a,13a-Didehydrodeguelin is a member of rotenones. Dehydrodeguelin is a natural product found in Tephrosia vogelii, Derris montana, and other organisms with data available.
(2E)-1-[3-(2,3-Dihydroxybenzyl)-2,4-dihydroxy-6-methoxyphenyl]-3-phenyl-2-propen-1-one
(-)-1,6-desoxytingtanoxide|(2R)-trans-2-acetoxy-3-(benzoyloxy)-1-<(benzoyloxy)methyl>cyclohexa-4,6-diene|(2R)-trans-2-acetoxy-3-(benzoyloxy)-1-[(benzoyloxy)methyl]cyclohexa-4,6-diene
6,7-dihydromonotropein|dihydromonotropein
C16H24O11 (392.13185539999995)
2-isopropenyl-3-hydroxydihydrofuranodemethylcalabaxanthone
2,4-dihydroxy-3-(2,6-dihydroxybenzyl)-6-methoxychalcone
1-(3-methoxy-4-hydroxybenzyl)-4-methoxyphenanthrene-2,6,7-triol
(1S,5R,7S,8S,9S)-7-acetoxy-10-chloro-5,11-dihydroxy-1-isovaleroxy-5,6-dihydrovaltrate chlorohydrin|chlorovaltrate G
1-(4-hydroxy-2-methylenebutanoate)-6-((S)-3,4-dihydroxy-2-methylenebutanoate)-beta-D-glucopyranose|tuliposide F
C16H24O11 (392.13185539999995)
pyranojacareubin
An organic heteropentacyclic compound that is 2H,6H,10H-dipyrano[3,2-b:2,3-i]xanthene substituted by hydroxy groups at positions 5 and 12, geminal methyl groups at positions 2 and 10 and an oxo group at position 6. Isolated from Calophyllum blancoi it exhibits antiviral activity.
OZESIOWEPLUEAF-QFIPXVFZSA-N
12-Ethyl-9-hydroxycamptothecin is a derivative of Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1].
5,9-Dimethyl-3-(3-methoxyphenyl)-psolen-6-yl propionic acid
(E)-1-[3-[(2,3-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
(E)-1-[3-[(2,3-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
Ala Ala Cys Glu
Ala Ala Glu Cys
Ala Cys Ala Glu
Ala Cys Glu Ala
Ala Asp Gly Met
Ala Asp Met Gly
Ala Glu Ala Cys
Ala Glu Cys Ala
Ala Gly Asp Met
Ala Gly Met Asp
Ala Met Asp Gly
Ala Met Gly Asp
Cys Ala Ala Glu
Cys Ala Glu Ala
Cys Asp Gly Val
Cys Asp Val Gly
Cys Glu Ala Ala
Cys Gly Asp Val
Cys Gly Val Asp
Cys Pro Ser Ser
Cys Ser Pro Ser
Cys Ser Ser Pro
Cys Val Asp Gly
Cys Val Gly Asp
Asp Ala Gly Met
Asp Ala Met Gly
Asp Cys Gly Val
Asp Cys Val Gly
Asp Gly Ala Met
Asp Gly Cys Val
Asp Gly Met Ala
Asp Gly Val Cys
Asp Met Ala Gly
Asp Met Gly Ala
Asp Val Cys Gly
Asp Val Gly Cys
Glu Ala Ala Cys
Glu Ala Cys Ala
Glu Cys Ala Ala
Glu Gly Gly Met
Glu Gly Met Gly
Glu Met Gly Gly
Gly Ala Asp Met
Gly Ala Met Asp
Gly Cys Asp Val
Gly Cys Val Asp
Gly Asp Ala Met
Gly Asp Cys Val
Gly Asp Met Ala
Gly Asp Val Cys
Gly Glu Gly Met
Gly Glu Met Gly
Gly Gly Glu Met
Gly Gly Met Glu
Gly Met Ala Asp
Gly Met Asp Ala
Gly Met Glu Gly
Gly Met Gly Glu
Gly Val Cys Asp
Gly Val Asp Cys
Met Ala Asp Gly
Met Ala Gly Asp
Met Asp Ala Gly
Met Asp Gly Ala
Met Glu Gly Gly
Met Gly Ala Asp
Met Gly Asp Ala
Met Gly Glu Gly
Met Gly Gly Glu
Pro Cys Ser Ser
Pro Ser Cys Ser
Pro Ser Ser Cys
Ser Cys Pro Ser
Ser Cys Ser Pro
Ser Pro Cys Ser
Ser Pro Ser Cys
Ser Ser Cys Pro
Ser Ser Pro Cys
Val Cys Asp Gly
Val Cys Gly Asp
Val Asp Cys Gly
Val Asp Gly Cys
Val Gly Cys Asp
Val Gly Asp Cys
Caryoptosidic acid
C16H24O11 (392.13185539999995)
Fenflumizole
C23H18F2N2O2 (392.1336271999999)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Sulfurous acid, ester, 2-chloroethyl-2-[2-[4-(1,1-dimethylethyl)phenoxy]-1-methylethoxy]-1-methylethyl ester
C18H29ClO5S (392.14241340000007)
3-methyl-2-[(1-methyl-2-phenyl-1H-indol-3-yl)azo]thiazolium acetate
(S)-3-(4-(2-amino-6-chloropyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid
C18H21ClN4O4 (392.12512560000005)
4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid
C18H21ClN4O4 (392.12512560000005)
Chloroprednisone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
cloprednol
H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
2-[({4-[2-(Trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
2-(3-Methylphenyl)sulfonyl-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetonitrile
3-(4-Benzoyl-piperazine-1-carbonyl)-8-methoxy-chromen-2-one
3-[3-(3-Methoxyphenyl)-5,9-dimethyl-7-oxofuro[3,2-g]chromen-6-yl]propanoic acid
(4r,5r)-5-Amino-1-[2-(1,3-Benzodioxol-5-Yl)ethyl]-4-(2,4,5-Trifluorophenyl)piperidin-2-One
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
1-[(3,4-Dimethoxyphenyl)sulfonyl]-4-(2-methoxyphenyl)piperazine
3-[[(2-Cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid
2-[[5-(2-Furanyl)-4-methyl-1,2,4-triazol-3-yl]thio]-1-(1,2,3,4-tetrahydrocarbazol-9-yl)ethanone
6,7,8,15,16,17-Hexahydro-7,16-methano-19-oxocyclodeca[1,2-b:6,7-b]dinaphthalene-5,18-dione
7-ethyl-10-hydroxycamptothecin
8-(5,5-dimethyl-4-oxofuran-3-yl)-5,7-dimethoxy-2-phenylchromen-4-one
16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
11,22-dihydroxy-7,7,19,19-tetramethyl-2,8,20-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,5,9,11,14,16(21),17-octaen-13-one
5-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
(12r,15s,16s)-14,14-dimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.0²,⁷.0¹²,¹⁶]hexadeca-1,4,7,9-tetraen-15-yl acetate
n-{3-[2-amino-3-(4-hydroxyphenoxy)phenyl]-3-oxopropyl}-4-hydroxybenzamide
(4ar,7r,7ar)-5,7-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)